RBC Capital analyst Arun Viswanathan lowered the firm’s price target on Chemours (CC) to $17 from $19 and keeps an Outperform rating on the shares after its Q3 earnings miss. The stock saw a positive reaction to the quarter but remains down over 25% YTD as pricing pressure remains in TiO2, and operational upsets in Advanced Performance Materials are offsetting gains in Thermal & Specialized Solutions, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: